Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Mirataz
Active substances:
Mirtazapine
Estonian, English, Latin
ATC code: QN06AX11
Dosage form: transdermal ointment
Strength: 20mg 1g
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Indication: For bodyweight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions (see section 5.1).
Safety features: No
Marketing authorization holder: Dechra Regulatory B.V. 
Marketing authorization number: EU/2/19/247 
Marketing authorization issued on: December 10, 2019 
Marketing authorization expires on: December 12, 2024 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1809097  Mirataz  transdermal ointment  20mg 1g 5g 1TK  Prescription      07.05.2024     
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere